Helen M. Thackray Glycomimetics Inc (GLYC) insider trading activity

GLYC Quotes by TradingView

Helen M. Thackray is SVP Clinical Development, CMO of GLYCOMIMETICS INC. Currently has a direct ownership of 183,115 shares of GLYC, which is worth approximately $78,739. The most recent transaction as insider was on Jan 20, 2021, when has been sold 34,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 183K
0% 3M change
0% 12M change
Total Value Held $78,739

Helen M. Thackray Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 20 2021
BUY
Grant, award, or other acquisition
-
34,500 Added 15.85%
183,115 Common Stock

Also insider at

BCRX
BIOCRYST PHARMACEUTICALS INC Healthcare
Chief R&D Officer
IMGN
ImmunoGen, Inc. Healthcare
Director
HMT

Helen M. Thackray

SVP Clinical Development, CMO
Durham, NC

Track Institutional and Insider Activities on GLYC

Follow GLYCOMIMETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GLYC shares.

Notify only if

Insider Trading

Get notified when an Glycomimetics Inc insider buys or sells GLYC shares.

Notify only if

News

Receive news related to GLYCOMIMETICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GLYC